Andere Sprachen Alimera Sciences, Inc.

Aktien

A2PVHE

US0162592028

ALIM

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 21.06.2024			% 5 Tage	% 1. Jan.
3,15 ^USD	+3,28 %		-0,63 %	-27,08 %

14.05.	Transcript : Alimera Sciences, Inc., Q1 2024 Earnings Call, May 14, 2024
14.05.	Alimera Sciences, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	04.06.
Alimera Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14.05.
Earnings Flash (ALIM) ALIMERA SCIENCES Posts Q1 Revenue $23M, vs. Street Est of $22.3M	14.05.
Alimera Sciences: Q1 Earnings Snapshot	14.05.
Alimera Sciences Reports First Quarter 2024 Results	14.05.
Alimera Announces Scientific Data Highlighting YUTIQ® to be Presented at Upcoming Association for Research in Vision and Ophthalmology and Retina World Congress Conferences	07.05.
Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update	30.04.
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	20.03.
Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network	19.03.
Alimera Sciences, Inc. Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network	19.03.
Alimera Sciences: Q4 Earnings Snapshot	07.03.
Alimera Sciences, Inc. Enters into the Seventh Amendment to Its Loan and Security Agreement	07.03.
Earnings Flash (ALIM) ALIMERA SCIENCES Posts Q4 Revenue $26.3M	07.03.
Earnings Flash (ALIM) ALIMERA SCIENCES Posts Q4 Revenue $26.3M	07.03.
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results	07.03.
Alimera Sciences, Inc. Provides Revenue Guidance for the Year 2024	07.03.
Alimera Sciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	07.03.
Alimera Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	07.03.
North American Morning Briefing : Powell Still in -2-	07.03.
Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate Update	29.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Alimera Sciences, Inc.

Aktien

A2PVHE

US0162592028

ALIM

Andere Sprachen

Filter